JP2023080234A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023080234A5 JP2023080234A5 JP2023065084A JP2023065084A JP2023080234A5 JP 2023080234 A5 JP2023080234 A5 JP 2023080234A5 JP 2023065084 A JP2023065084 A JP 2023065084A JP 2023065084 A JP2023065084 A JP 2023065084A JP 2023080234 A5 JP2023080234 A5 JP 2023080234A5
- Authority
- JP
- Japan
- Prior art keywords
- hpmcas
- liquid solution
- ethenocycloprop
- isoindol
- octahydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361856240P | 2013-07-19 | 2013-07-19 | |
| US61/856,240 | 2013-07-19 | ||
| JP2020195121A JP7681393B2 (ja) | 2013-07-19 | 2020-11-25 | アモルファステコビリマット調製 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020195121A Division JP7681393B2 (ja) | 2013-07-19 | 2020-11-25 | アモルファステコビリマット調製 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023080234A JP2023080234A (ja) | 2023-06-08 |
| JP2023080234A5 true JP2023080234A5 (https=) | 2025-07-02 |
Family
ID=52346653
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016526997A Active JP6843616B2 (ja) | 2013-07-19 | 2014-07-11 | アモルファステコビリマット調製 |
| JP2020195121A Active JP7681393B2 (ja) | 2013-07-19 | 2020-11-25 | アモルファステコビリマット調製 |
| JP2023065084A Pending JP2023080234A (ja) | 2013-07-19 | 2023-04-12 | アモルファステコビリマット調製 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016526997A Active JP6843616B2 (ja) | 2013-07-19 | 2014-07-11 | アモルファステコビリマット調製 |
| JP2020195121A Active JP7681393B2 (ja) | 2013-07-19 | 2020-11-25 | アモルファステコビリマット調製 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US9670158B2 (https=) |
| EP (2) | EP3763702B1 (https=) |
| JP (3) | JP6843616B2 (https=) |
| CN (2) | CN111635353A (https=) |
| AU (1) | AU2014290333B2 (https=) |
| CA (3) | CA3246369A1 (https=) |
| IL (1) | IL242331B (https=) |
| WO (1) | WO2015009566A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015009566A1 (en) * | 2013-07-19 | 2015-01-22 | Siga Technologies, Inc. | Amorphous tecovirimat preparation |
| CN107126419B (zh) * | 2016-02-26 | 2020-06-19 | 石药集团中诺药业（石家庄）有限公司 | 一种奥贝胆酸片剂及其制备方法 |
| CN112955130A (zh) * | 2018-10-30 | 2021-06-11 | 佩洛通治疗公司 | 包含取代茚满的固体分散体和药物组合物及其制备和使用方法 |
| CN115141136B (zh) * | 2021-03-31 | 2023-06-20 | 中国人民解放军军事科学院军事医学研究院 | 特考韦瑞药的共晶及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20011184A1 (es) | 2000-03-16 | 2001-11-15 | Pfizer Prod Inc | Composiciones farmaceuticas de inhibidores de la glucogeno-fosforilasa |
| US6596771B2 (en) | 2001-01-12 | 2003-07-22 | Schering Corporation | Drugs for treating viral infections |
| US6433016B1 (en) | 2001-01-12 | 2002-08-13 | Vassil Stefanov Georgiev | Drugs for treating viral infections |
| US7687641B2 (en) | 2003-06-20 | 2010-03-30 | Siga Technologies, Inc. | Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| EP1638938B1 (en) * | 2003-06-20 | 2017-04-12 | Siga Technologies Inc. | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| US8642577B2 (en) * | 2005-04-08 | 2014-02-04 | Chimerix, Inc. | Compounds, compositions and methods for the treatment of poxvirus infections |
| JP2010526848A (ja) * | 2007-05-11 | 2010-08-05 | エフ．ホフマン−ラ ロシュ アーゲー | 難溶性薬物用の医薬組成物 |
| JP6018041B2 (ja) | 2010-03-23 | 2016-11-02 | シガ・テクノロジーズ・インコーポレーテッド | Ｓｔ−２４６の多形型および調製方法 |
| BR112012031516A2 (pt) * | 2010-06-09 | 2016-11-08 | Abbott Lab | dispersões sólidas contendo inibidores de quinase |
| GB201103837D0 (en) * | 2011-03-07 | 2011-04-20 | Oxagen Ltd | Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-Indol-1-Yl)-acetic acid |
| US8591944B2 (en) * | 2011-03-08 | 2013-11-26 | Zalicus Pharmaceuticals Ltd. | Solid dispersion formulations and methods of use thereof |
| WO2013056108A2 (en) * | 2011-10-14 | 2013-04-18 | Array Biopharma Inc. | Solid dispersion |
| JP2013103899A (ja) * | 2011-11-11 | 2013-05-30 | Fuji Chem Ind Co Ltd | 難溶性薬物の新規な固体分散体 |
| CN102406617B (zh) * | 2011-11-30 | 2013-08-28 | 中国人民解放军军事医学科学院生物工程研究所 | 一种替韦立马干混悬剂及其制备方法 |
| WO2015009566A1 (en) | 2013-07-19 | 2015-01-22 | Siga Technologies, Inc. | Amorphous tecovirimat preparation |
-
2014
- 2014-07-11 WO PCT/US2014/046340 patent/WO2015009566A1/en not_active Ceased
- 2014-07-11 CA CA3246369A patent/CA3246369A1/en active Pending
- 2014-07-11 CA CA3128535A patent/CA3128535C/en active Active
- 2014-07-11 CA CA2917199A patent/CA2917199C/en active Active
- 2014-07-11 CN CN202010516675.7A patent/CN111635353A/zh active Pending
- 2014-07-11 EP EP20190932.2A patent/EP3763702B1/en active Active
- 2014-07-11 AU AU2014290333A patent/AU2014290333B2/en active Active
- 2014-07-11 JP JP2016526997A patent/JP6843616B2/ja active Active
- 2014-07-11 EP EP14825621.7A patent/EP3021836B1/en active Active
- 2014-07-11 CN CN201480026785.8A patent/CN105307636A/zh active Pending
- 2014-07-11 US US14/903,083 patent/US9670158B2/en active Active
-
2015
- 2015-10-29 IL IL242331A patent/IL242331B/en active IP Right Grant
-
2017
- 2017-04-27 US US15/498,787 patent/US9889119B2/en active Active
-
2018
- 2018-01-02 US US15/860,262 patent/US10045963B2/en active Active
-
2020
- 2020-11-25 JP JP2020195121A patent/JP7681393B2/ja active Active
-
2023
- 2023-04-12 JP JP2023065084A patent/JP2023080234A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023080234A5 (https=) | ||
| JP2719344B2 (ja) | 徐放性製剤 | |
| RU2372893C2 (ru) | Содержащий фармацевтический агент состав с покрытием | |
| JP2009538315A (ja) | 塩酸デュロキセチン遅延放出型製剤 | |
| CN1419446A (zh) | 缓释制剂及其制法 | |
| RU2008109651A (ru) | Ядра микропеллет панкреатина, пригодные для нанесения энтеросолюбильного покрытия | |
| CN1489455A (zh) | 延释药物制剂 | |
| CN102970982B (zh) | 肠溶片剂 | |
| JP2010077144A (ja) | 持続性製剤 | |
| RU2602955C2 (ru) | Фармацевтические композиции антагонистов метаботропного глутаматного рецептора 5 (mglu5) | |
| KR20110117199A (ko) | 유기 화합물의 생약 제제 | |
| CN110123782A (zh) | 含有药物的中空颗粒 | |
| JP2024506595A5 (https=) | ||
| JP2002529399A (ja) | 粒状化結晶性イブプロフェンで被覆した粒子 | |
| CA2555295C (en) | Extended release coated mini-tablets of venlafaxine hydrochloride | |
| JP2007507491A (ja) | 徐放性製剤 | |
| JP2016527229A5 (https=) | ||
| CA2586124A1 (en) | Formulations of [1,4]diazepino[6,7,1-ij]quinoline derivatives | |
| RU2423105C2 (ru) | Фармацевтическая композиция с контролируемым высвобождением венлафаксина гидрохлорида и способ ее получения | |
| US20050186276A1 (en) | Pharmaceutical formulations | |
| US20040228916A1 (en) | Pharmaceutical solid preparation containing a poorly soluble drug and production process thereof | |
| AU2012227936A1 (en) | Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor | |
| CN1839846A (zh) | 左氧氟沙星缓释微丸、其制备方法及其用途 | |
| CN1549705A (zh) | 新的缓释口服剂型 | |
| RU2727721C2 (ru) | Фармацевтическая композиция с замедленным высвобождением, содержащая ривастигмин |